Severe Hyperkalemia Rare Despite Dual RAAS Blockade
Analysis of data from the HALT PKD trial showed that 0% to 0.4% of patients experienced potassium levels above 6.5 mEq/L.
Analysis of data from the HALT PKD trial showed that 0% to 0.4% of patients experienced potassium levels above 6.5 mEq/L.
It develops in 8% of patients overall and 15.1% of patients with stage 5 CKD.
Increased risk observed in the VA health system unlikely to be fully explained by disparities in access to care.
Caring for hypernatremia patients also involved greater resource consumption.
High levels of soluble urokinase-type plasminogen activator receptor are associated with an elevated CKD risk in individuals with normal eGFR.
Meta-analysis suggests a 9% decreased 5-year mortality risk associated with pre-transplant peritoneal dialysis versus hemodialysis.
Study shows that it increases urine volume and decreases supersaturation with stone-forming calcium salts.
Significant association found in patients with diabetic nephropathy.
AKI is independently associated with a 27% increased risk of heart failure, according to a study of hospitalized U.S. veterans.
AKI developed in 2.1% of operations and was more common after major, open, and acute surgeries.